AttendMe Owl Logo
AttendMe
Evidence Evolution
Upper GI SurgeryUpper GI Surgery

How This Evidence Evolved

Esophagectomy Surgical Approach

From Open Transthoracic to Minimally Invasive and Robotic Esophagectomy

32.1

Timeline

Signal

Early observations and pilot data that first suggested a new direction

TIME compared minimally invasive with open transthoracic esophagectomy at five centers in three countries. Patients had resectable esophageal or gastro-esophageal junction cancer. Pulmonary infection within 2 weeks occurred in 9% with minimally invasive surgery versus 29% with open surgery (RR 0.30; 95% CI 0.12–0.76; p=0.005). During the full hospital stay, infection rates were 12% versus 34%. This provided randomized evidence of short-term benefit from the minimally invasive approach.
Proof

Landmark RCTs and pivotal trials that established the evidence base

MIRO compared hybrid minimally invasive esophagectomy with open surgery. Hybrid surgery combined laparoscopic gastric mobilization with open right thoracotomy. Major intraoperative or postoperative complications within 30 days occurred in 36% with hybrid surgery versus 64% with open surgery (OR 0.31; 95% CI 0.18–0.55; p<0.001). Major pulmonary complications occurred in 18% versus 30%. At 3 years, overall survival was 67% versus 55%, and disease-free survival was 57% versus 48%. The report found lower morbidity without compromising survival over the reported follow-up.
Extension

Follow-up studies, subgroup analyses, and real-world validation

ROBOT randomized 112 patients with resectable intrathoracic esophageal cancer to robot-assisted minimally invasive thoracolaparoscopic esophagectomy (RAMIE) or open transthoracic surgery. Overall surgery-related postoperative complications occurred in 59% versus 80% (RR 0.74, 95% CI 0.57–0.96; P=.02). Quality of life was better at discharge and 6 weeks after discharge. Oncological outcomes were comparable at 40-month follow-up; this is not a formal equivalence result. The trial supports lower morbidity relative to its open comparator.
Guidelines

Integration into clinical practice guidelines and recommendations

ESMO
Now

Current standard of care and ongoing research directions

TIME, MIRO and ROBOT support minimally invasive approaches through different postoperative outcomes and techniques. TIME found fewer pulmonary infections; MIRO found fewer major complications with hybrid surgery; ROBOT found fewer surgery-related complications with RAMIE. MIRO reported 3-year survival outcomes and ROBOT reported comparable oncological outcomes at 40 months. These results should not be converted into a universal claim of oncological equivalence or superiority of robotics over conventional MIE. Technique selection also requires judgment about the patient and available surgical expertise.

Landmark Trials in This Story

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.

Related Evidence

Frequently Asked Questions

Which esophagectomy approach produces the best outcomes?+
TIME found fewer pulmonary infections with minimally invasive surgery. MIRO found major intraoperative or postoperative complications in 36% with hybrid versus 64% with open surgery. ROBOT randomized 112 patients and found surgery-related postoperative complications of 59% with RAMIE versus 80% with open surgery. These are distinct morbidity results; they do not establish formal oncological equivalence across all three trials.
Is robotic esophagectomy better than standard minimally invasive esophagectomy?+
ROBOT compared RAMIE with open transthoracic surgery, finding fewer surgery-related complications (59% vs 80%) and better short-term recovery and quality of life. It did not compare robotics with conventional MIE, so its results do not establish superiority over that approach.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Claims checked against cited sources: 10 November 2026